Assay and Drug Development Technologies
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q3 | 27.8% | 0.327 | Q3 | 46.4% |
| 2024 | 1.7 | Q3 | 27.8% | 0.308 | Q3 | 46.5% |
| 2023 | 1.6 | Q3 | 28.0% | 0.317 | Q3 | 50.5% |
| 2022 | 1.8 | Q4 | 27.8% | 0.358 | Q3 | 56.0% |
| 2021 | 2.5 | Q3 | 43.6% | 0.394 | Q3 | 59.8% |
| 2020 | — | — | 0.402 | Q3 | 59.6% | |
| 2019 | — | — | 0.568 | Q2 | 71.0% | |
| 2018 | — | — | 0.687 | Q2 | 74.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1557-8127
ISSN
1540-658X
region
Northern America
coverage
2002-2026